TopMarketGainers
Long

AMAG PHARMACEUTICALS LONG INTO EARNINGS.

NASDAQ:AMAG   AMAG PHARMACEUTICS INC
Without taking fundamentals into consideration we believe the stock is setting up for a nice move on earnings .
Final consideration will be made before close of trade today, if price reaction is good it will confirm our bullish belief.
AVERAGE ANALYSTS PRICE TARGET $14
AVERAGE ANALYSTS RECOMMENDATION Hold
P/E RATIO
SHORT INTEREST 31%%
COMPANY PROFILE
AMAG Pharmaceuticals , Inc. is a biopharmaceutical company, which focuses on the research, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Makena, CBR , Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Do you want to GAIN an Edge on Wall Street?

1) Sign Up for Free @ http://www.TopMarketGainers.com

2) Follow our Telegram Channel @ https://t.me/TopMarketGainers

3) Join our LIVE CHAT on our Discord @ https://invite.gg/topmarketgainers

Comments

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out